from a health delivery, health quality, and operational perspective, and the acquisition process that could be used to procure such solutions. (4) An analysis of electronic health record and health information technology market trends, capabilities, and market leaders to include user satisfaction and health outcome statistics to the extent they are relevant to the goals and strategy of the Department. (5) An analysis of whether the Department choosing an alternative path or paths would, and to what extent, or would not impact necessary alignment with the electronic health record modernization conducted by the Department of Defense commonly known as MHS GENESIS. (6) An analysis of whether the ability to share and exchange records in an interoperable manner, and with what level of interoperability, with the Department of Defense would be negatively impacted or positively enhanced, or neither, by an alternative technology path or contract. (7) An analysis of whether the ability share and exchange records in an interoperable manner, and with what level of interoperability, with non-Federal health entities would be negatively impacted or positively enhanced, or neither, by an alternative technology path or contract. (8) An estimated timeline to restart deployment of a new electronic health record of the Department with a different vendor based on an alternative technology path or contract. (9) An assessment of options that may include— (A) a narrow or descoped contract supplemented by other contracts to strengthen areas in which the Oracle-Cerner product performs in a substandard fashion or is inadequate to the health delivery and operational needs of the Department